Actual Medicinal Product (AMP) - Uprima 3mg sublingual tablets (Abbott Laboratories Ltd)
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Uprima 3mg sublingual tablets | Start Date 28-10-2002 | End Date |
Summary
- Discontinued
- Licensed Route
- Sublingual
- Availability Restrictions
- Not available
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
Codes
| BNF | Start Date | End Date |
|---|---|---|
| Previous BNF 07040500 | Start Date 23-06-2005 | End Date 10-10-2006 |
| Code | Start Date | End Date |
|---|---|---|
| 416011000001105 | 28-10-2002 |
Parent Products
-
VTMApomorphine
-
VMPApomorphine 3mg sublingual tablets sugar free
-
AMP(Current) Uprima 3mg sublingual tablets ...
-
-
Actual Medicinal Product Pack (AMPP) Information
| Pack Size | Indicative Price | Discontinued |
|---|---|---|
| 2 tablet | ||
| 4 tablet |